Liquorice ingestion attenuates vasodilatation via exogenous nitric oxide donor but not via β2-adrenoceptor stimulation

Elina J Hautaniemi, Antti J Tikkakoski, Arttu Eräranta, Mika Kähönen, Esa Hämäläinen, Ursula Turpeinen, Heini Huhtala, Jukka Mustonen, Ilkka H Pörsti, Elina J Hautaniemi, Antti J Tikkakoski, Arttu Eräranta, Mika Kähönen, Esa Hämäläinen, Ursula Turpeinen, Heini Huhtala, Jukka Mustonen, Ilkka H Pörsti

Abstract

We examined the effect of liquorice ingestion on haemodynamic responses to exogenous nitric oxide donor (nitroglycerin) and β2-adrenoceptor agonist (salbutamol), and 11β-hydroxysteroid dehydrogenase activity, in 21 volunteers and 21 reference subjects. Haemodynamic data was captured before and after sublingual nitroglycerin (0.25 mg) and inhaled salbutamol (400 μg) during orthostatic challenge utilising radial pulse wave analysis and whole-body impedance cardiography. The recordings were performed at baseline and following two weeks of liquorice intake (290-370 mg/d glycyrrhizin). Urinary cortisone and cortisol metabolites were examined. Liquorice intake elevated aortic systolic and diastolic blood pressure and systemic vascular resistance when compared with the reference group. Following research drug administration the liquorice-induced increase in systemic vascular resistance was observed in the presence of nitroglycerin (p<0.05) but no longer in the presence of salbutamol. Liquorice ingestion decreased cardiac chronotropic response to upright posture (p = 0.032) in unadjusted analysis, but when adjusted for age and sex the difference in the upright change in heart rate was no longer significant. The urinary cortisone to cortisol metabolite ratio decreased from 0.70 to 0.31 (p<0.001) after liquorice intake indicating significant inhibition of the 11β-hydroxysteroid dehydrogenase type 2. In the reference group the haemodynamic variables remained virtually unchanged. These results suggest that liquorice exposure impaired vasodilatation in vivo that was induced by exogenous nitric oxide donor but not that induced by β2-adrenoceptor stimulation. Trial registration: EU Clinical Trials Register 2006-002065-39 ClinicalTrials.gov NCT01742702.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. The CONSORT flow diagram of…
Fig 1. The CONSORT flow diagram of study participants.
Fig 2. Aortic blood pressure at baseline…
Fig 2. Aortic blood pressure at baseline and after the follow-up (reference group) or intervention (liquorice ingestion).
Systolic (a, b) and diastolic (c, d) blood pressure were measured in the absence (0–15 min) and presence (16–30 min) of sublingual nitroglycerin during supine position and orthostatic challenge. The passive head-up tilt was carried out from 5 to 10 min, and 20 to 25 min. Mean and standard error of the mean, statistical analyses compared the difference of the area under the curve between visit 1 and visit 2 in the liquorice versus the reference group, adjusted for age and sex.
Fig 3. Heart rate and augmentation index…
Fig 3. Heart rate and augmentation index in the absence and presence of sublingual nitroglycerin.
Heart rate (a, b) and augmentation index (c, d) were measured at baseline and after the follow-up. Mean and standard error of the mean, the difference of the area under the curve between visit 1 and visit 2 was compared in the liquorice versus the reference group, adjusted for age and sex.
Fig 4. Liquorice intake and urinary glucocorticoid…
Fig 4. Liquorice intake and urinary glucocorticoid excretion.
The urinary ratio of tetrahydrocortisone to tetrahydrocortisol at baseline and after two weeks of liquorice ingestion, grey lines depict each individual, thick black line depicts mean values, n = 22.
Fig 5. Cardiac index and systemic vascular…
Fig 5. Cardiac index and systemic vascular resistance index in the absence and presence of sublingual nitroglycerin.
Cardiac index (a, b) and systemic vascular resistance index (c, d) were measured at baseline and after the follow-up. Mean and standard error of the mean, the difference of the area under the curve between visit 1 and visit 2 was compared in the liquorice versus the reference group, adjusted for age and sex.
Fig 6. Heart rate and augmentation index…
Fig 6. Heart rate and augmentation index in the absence and presence of salbutamol inhalation.
Heart rate (a, b) and augmentation index (c, d) were measured at baseline and after the follow-up. Mean and standard error of the mean, the difference of the area under the curve between visit 1 and visit 2 was compared in the liquorice versus the reference group, adjusted for age and sex.
Fig 7. Cardiac index and systemic vascular…
Fig 7. Cardiac index and systemic vascular resistance index in the absence and presence of salbutamol inhalation.
Cardiac index (a, b) and systemic vascular resistance index (c, d) were measured at baseline and after the follow-up. Mean and standard error of the mean, the difference of the area under the curve between visit 1 and visit 2 was compared in the liquorice versus the reference group, adjusted for age and sex.
Fig 8. Summary of the mechanisms of…
Fig 8. Summary of the mechanisms of liquorice-induced elevation in blood pressure.

References

    1. Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of glycyrrhiza glabra (licorice): a review. Phytother Res. 2017;31: 1635–1650. 10.1002/ptr.5893
    1. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006;46: 167–192. 10.1016/j.yrtph.2006.06.002
    1. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2: 821–824. 10.1016/s0140-6736(87)91014-2
    1. Hunter RW, Bailey MA. Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension. Curr Opin Pharmacol. 2015;21: 105–114. 10.1016/j.coph.2015.01.005
    1. Goodwin JE, Geller DS. Glucocorticoid-induced hypertension. Pediatr Nephrol. 2012;27: 1059–1066. 10.1007/s00467-011-1928-4
    1. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988;242: 583–585. 10.1126/science.2845584
    1. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase—tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2: 986–989. 10.1016/s0140-6736(88)90742-8
    1. Farese RV, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N Engl J Med. 1991;325: 1223–1227. 10.1056/NEJM199110243251706
    1. Hadoke PWF, Macdonald L, Logie JJ, Small GR, Dover AR, Walker BR. Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function. Cell Mol Life Sci. 2006;63: 565–578. 10.1007/s00018-005-5427-2
    1. Christy C, Hadoke PWF, Paterson JM, Mullins JJ, Seckl JR, Walker BR. 11β-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids. Hypertension. 2003;42: 580–587. 10.1161/01.HYP.0000088855.06598.5B
    1. Hatakeyama H, Inaba S, Takeda R, Miyamori I. 11beta-hydroxysteroid dehydrogenase in human vascular cells. Kidney Int. 2000;57: 1352–1357. 10.1046/j.1523-1755.2000.00974.x
    1. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18: 50–55. 10.1016/j.amjhyper.2004.08.026
    1. Chapman K, Holmes M, Seckl J. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93: 1139–1206. 10.1152/physrev.00020.2012
    1. Lombès M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation. 1995;92: 175–182. 10.1161/01.cir.92.2.175
    1. Richardson RV, Batchen EJ, Denvir MA, Gray GA, Chapman KE. Cardiac GR and MR: From Development to Pathology. Trends Endocrinol Metab. 2016;27: 35–43. 10.1016/j.tem.2015.10.001
    1. Oakley RH, Cidlowski JA. Glucocorticoid signaling in the heart: A cardiomyocyte perspective. J Steroid Biochem Mol Biol. 2015;153: 27–34. 10.1016/j.jsbmb.2015.03.009
    1. Hautaniemi EJ, Tahvanainen AM, Koskela JK, Tikkakoski AJ, Kähönen M, Uitto M, et al. Voluntary liquorice ingestion increases blood pressure via increased volume load, elevated peripheral arterial resistance, and decreased aortic compliance. Sci Rep. 2017;7: 10947 10.1038/s41598-017-11468-7
    1. Leskinen MH, Hautaniemi EJ, Tahvanainen AM, Koskela JK, Päällysaho M, Tikkakoski AJ, et al. Daily liquorice consumption for two weeks increases augmentation index and central systolic and diastolic blood pressure. PloS One. 2014;9: e105607 10.1371/journal.pone.0105607
    1. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141: 929–937. 10.7326/0003-4819-141-12-200412210-00009
    1. Turpeinen U, Markkanen H, Sane T, Hämäläinen E. Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest. 2006;66: 147–159. 10.1080/00365510500474504
    1. Tahvanainen A, Koskela J, Tikkakoski A, Lahtela J, Leskinen M, Kähönen M, et al. Analysis of cardiovascular responses to passive head-up tilt using continuous pulse wave analysis and impedance cardiography. Scand J Clin Lab Invest. 2009;69: 128–137. 10.1080/00365510802439098
    1. Tahvanainen AM, Tikkakoski AJ, Leskinen MH, Nordhausen K, Kähönen M, Kööbi T, et al. Supine and upright haemodynamic effects of sublingual nitroglycerin and inhaled salbutamol: a double-blind, placebo-controlled, randomized study. J Hypertens. 2012;30: 297–306. 10.1097/HJH.0b013e32834e4b26
    1. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95: 1827–1836. 10.1161/01.cir.95.7.1827
    1. Kööbi T, Kaukinen S, Ahola T, Turjanmaa VM. Non-invasive measurement of cardiac output: whole-body impedance cardiography in simultaneous comparison with thermodilution and direct oxygen Fick methods. Intensive Care Med. 1997;23: 1132–1137. 10.1007/s001340050469
    1. Kööbi T, Kaukinen S, Turjanmaa VM, Uusitalo AJ. Whole-body impedance cardiography in the measurement of cardiac output. Crit Care Med. 1997;25: 779–785. 10.1097/00003246-199705000-00012
    1. Kööbi T, Kähönen M, Iivainen T, Turjanmaa V. Simultaneous non-invasive assessment of arterial stiffness and haemodynamics—a validation study. Clin Physiol Funct Imaging. 2003;23: 31–36.
    1. Koskela JK, Tahvanainen A, Haring A, Tikkakoski AJ, Ilveskoski E, Viitala J, et al. Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects. BMC Cardiovasc Disord. 2013;13: 102 10.1186/1471-2261-13-102
    1. Wilenius M, Tikkakoski AJ, Tahvanainen AM, Haring A, Koskela J, Huhtala H, et al. Central wave reflection is associated with peripheral arterial resistance in addition to arterial stiffness in subjects without antihypertensive medication. BMC Cardiovasc Disord. 2016;16: 131 10.1186/s12872-016-0303-6
    1. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22: 147–152. 10.1161/hq0102.101770
    1. Tahvanainen A, Koskela J, Leskinen M, Ilveskoski E, Nordhausen K, Kähönen M, et al. Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. Br J Clin Pharmacol. 2011;71: 41–51. 10.1111/j.1365-2125.2010.03794.x
    1. Calculation of within-case area under function curve by trapezoidal integration [Internet] [cited 15 August 2019]. Available from:
    1. Streiner DL. Control or overcontrol for covariates? Evid Based Ment Health. 2016;19: 4–5. 10.1136/eb-2015-102294
    1. Roberts C, Torgerson DJ. Understanding controlled trials: baseline imbalance in randomised controlled trials. BMJ. 1999;319: 185 10.1136/bmj.319.7203.185
    1. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46: 1753–1760. 10.1016/j.jacc.2005.07.037
    1. Kangas P, Tahvanainen A, Tikkakoski A, Koskela J, Uitto M, Viik J, et al. Increased Cardiac Workload in the Upright Posture in Men: Noninvasive Hemodynamics in Men Versus Women. J Am Heart Assoc. 2016;5 10.1161/JAHA.115.002883
    1. Hautaniemi EJ, Tikkakoski AJ, Tahvanainen A, Nordhausen K, Kähönen M, Mattsson T, et al. Effect of fermented milk product containing lactotripeptides and plant sterol esters on haemodynamics in subjects with the metabolic syndrome—a randomised, double-blind, placebo-controlled study. Br J Nutr. 2015;114: 376–386. 10.1017/S0007114515002032
    1. Hammer F, Stewart PM. Cortisol metabolism in hypertension. Best Pract Res Clin Endocrinol Metab. 2006;20: 337–353. 10.1016/j.beem.2006.07.001
    1. Epstein MT, Espiner EA, Donald RA, Hughes H. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J. 1977;1: 488–490. 10.1136/bmj.1.6059.488
    1. Quaschning T, Ruschitzka F, Shaw S, Lüscher TF. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension. 2001;37: 801–805. 10.1161/01.hyp.37.2.801
    1. Ruschitzka F, Quaschning T, Noll G, deGottardi A, Rossier MF, Enseleit F, et al. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide. Circulation. 2001;103: 3129–3135. 10.1161/01.cir.103.25.3129
    1. Evans LC, Ivy JR, Wyrwoll C, McNairn JA, Menzies RI, Christensen TH, et al. Conditional deletion of hsd11b2 in the brain causes salt appetite and hypertension. Circulation. 2016;133: 1360–1370. 10.1161/CIRCULATIONAHA.115.019341
    1. Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 β-HSD by liquorice. J Hum Hypertens. 2003;17: 1001504 10.1038/sj.jhh.1001504
    1. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation. 1997;95: 2293–2297. 10.1161/01.cir.95.9.2293
    1. Ferro A, Coash M, Yamamoto T, Rob J, Ji Y, Queen L. Nitric oxide-dependent β2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt. Br J Pharmacol. 2004;143: 397–403. 10.1038/sj.bjp.0705933
    1. Sobieszczyk P, Borlaug BA, Gornik HL, Knauft WD, Beckman JA. Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans. Clin Sci. 2010;119: 437–442. 10.1042/CS20100087
    1. Hadoke PW, Christy C, Kotelevtsev YV, Williams BC, Kenyon CJ, Seckl JR, et al. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation. 2001;104: 2832–2837. 10.1161/hc4801.100077
    1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27: 2588–2605. 10.1093/eurheartj/ehl254
    1. Dart AM, Kingwell BA. Pulse pressure—a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37: 975–984. 10.1016/s0735-1097(01)01108-1
    1. McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. 2006;48: 602–608. 10.1161/01.HYP.0000239206.64270.5f
    1. Tikkakoski AJ, Kangas P, Suojanen L, Tahvanainen AM, Eräranta A, Kähönen MAP, et al. Salbutamol-induced decrease in augmentation index is related to the parallel increase in heart rate. Basic Clin Pharmacol Toxicol. 2018; 10.1111/bcpt.12988
    1. Tahvanainen A, Leskinen M, Koskela J, Ilveskoski E, Alanko J, Kähönen M, et al. Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin. Br J Clin Pharmacol. 2009;68: 23–33. 10.1111/j.1365-2125.2009.03434.x
    1. Omar HR, Komarova I, El-Ghonemi M, Fathy A, Rashad R, Abdelmalak HD, et al. Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab. 2012;3: 125–138. 10.1177/2042018812454322
    1. Simpson FO, Currie IJ. Licorice consumption among high school students. N Z Med J. 1982;95: 31–33.
    1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39: 3021–3104. 10.1093/eurheartj/ehy339
    1. Sigurjonsdottir HA, Axelson M, Johannsson G, Manhem K, Nyström E, Wallerstedt S. The liquorice effect on the RAAS differs between the genders. Blood Press. 2006;15: 169–172. 10.1080/08037050600593060

Source: PubMed

Подписаться